Funded Startups in Rockville
Rockville entries span 2020-03-25 (Sepio Systems) through 2026-05-22 (Camber Creek), with the most recent cluster tightening in 2025-11 to 2026-05.
Rockville entries span 2020-03-25 (Sepio Systems) through 2026-05-22 (Camber Creek), with the most recent cluster tightening in 2025-11 to 2026-05. The size distribution is highly top-heavy: the largest disclosed round is XENERGY’s $700M Series D on 2025-11-27, which dwarfs the next-largest disclosed amounts (Avalo Therapeutics at $431M on 2026-05-05, and SciNeuro at $53M on 2025-12-04). Below the top two, many disclosed rounds sit in the low tens of millions or less (e.g., greatEvent at $500K on 2026-04-15; AccufyDx at $200K on 2025-09-30). Sector-wise, biotech appears repeatedly (e.g., Avalo Therapeutics 2026-05-05; CASI Pharmaceuticals 2025-12-11; SciNeuro 2025-12-04; REGENXBIO 2025-05-19; AgNovos Bioscience 2023-06-09; TissueGene 2023-05-15), while most rounds are labeled “Series Unknown” (19 of 34) and several disclose no amount (2 additional rows marked “undisclosed”).
Most recent rounds
34 shownRelated listings
Frequently asked
What stands out in round size for Rockville, and how extreme is it versus the rest?
XENERGY’s $700M Series D on 2025-11-27 is the clear outlier: the next-largest disclosed rounds are Avalo Therapeutics at $431M (2026-05-05) and then SciNeuro at $53M (2025-12-04). Many other disclosed amounts are far smaller, such as greatEvent at $500K (2026-04-15) and AccufyDx at $200K (2025-09-30).
How concentrated are deals in the most recent period covered by these 34 rows?
The latest 90-day window is heavily represented by late 2025 through mid-2026 closes: examples include XENERGY ($700M) on 2025-11-27, OncoC4 ($50M) on 2025-10-05, and Avalo Therapeutics ($431M) on 2026-05-05. The oldest dated entries are in 2020 (Sepio Systems on 2020-03-25 and 3CLogic on 2020-03-30), so recency is where the density sits.
Are any sectors over-represented, based on the repeated labels in this list?
Biotechnology shows up across multiple separate entries and dates (e.g., CASI Pharmaceuticals $20M on 2025-12-11; REGENXBIO $150M on 2025-05-19; AgNovos Bioscience $32M on 2023-06-09; TissueGene $30M on 2023-05-15). Other categories appear, but none repeat as consistently as biotech in these rows.
What does the stage mix look like, and do “Series Unknown” labels dominate?
Yes. “Series Unknown” accounts for 19 of 34 rows (for example, Camber Creek on 2026-05-22 and OS Therapies on 2026-04-02), while “undisclosed” amounts appear on 2 rows (Camber Creek 2026-05-22 and US Fertility 2025-11-25). When amounts are disclosed, the largest clearly tied to a stage is XENERGY’s $700M Series D (2025-11-27).
Which Rockville listings are the smallest disclosed rounds, and how do they compare to the top end?
The smallest disclosed amount shown is Quantum Space at $60K (2025-02-19), followed by greatEvent at $500K (2026-04-15) and AccufyDx at $200K (2025-09-30). Relative to the top disclosed round (XENERGY’s $700M on 2025-11-27), these low six-figure or sub-million figures are orders of magnitude smaller and indicate wide funding dispersion within the same geography list.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.